MedTrace Logo

Balloon-expandable DES for ICAS Registry Study (BDES-ICAS Registry)

NCT06614972 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2024-09-26

No results posted yet for this study

Summary

To study the clinical outcomes after implantation of balloon-expandable drug-eluting stents in patients with symptomatic intracranial atherosclerotic stenosis in prevention of composite event of any stroke and death within 30 days and ischemic stroke in the territories of the responsible artery from 31 days to 1-year.

Conditions

  • Atheroscleroses, Cerebral
  • Intracranial Atherosclerosis
  • Ischemia Stroke

Interventions

DEVICE

Balloon-expandable drug-eluting stent

Balloon-expandable drug-eluting stent (BDES) is the device comprises of a balloon expandable sirolimus eluting stent and a delivery catheter that features a rapid exchange catheter design with a semi-compliant balloon located at its distal end.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Jieqing Wan · RenJi Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-09-30
Completion
2030-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614972 on ClinicalTrials.gov